Avila Therapeutics' Corporate Minority Round

Avila Therapeutics raised a round of funding on May 25, 2010. Investors include Clovis Oncology.

Avila Therapeutics is developing new medicines that achieve 'protein silencing' based on the proprietary Avilomics platform. Per the company, these medicines, called covalent drugs, strongly and resil…

Articles about Avila Therapeutics' Corporate Minority Round: